Wall Street analyst estimates for Protagenic Therapeutics, Inc. (PTIX): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Valuation Ratios
| P/E Ratio | 0.28 |
| Price / Book | 0.88 |
| EV / EBITDA | -0.35 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | $534 | $148 | $347 | $339 | $286 | 0 | $30 | $28218 | $50286 | $37715 |
| Gross Profit | -$534 | -$148 | -$347 | -$339 | -$286 | 0 | -$30 | -$28218 | -$50286 | -$37715 |
| Research & Development | $417866 | $717452 | $881186 | $807947 | $699797 | $1.1M | $1.6M | $3.3M | $3.8M | $1.7M |
| Selling, General & Admin | $1.3M | $1.6M | $1.4M | $1.3M | $1.9M | $3.0M | $2.0M | $1.2M | $1.8M | $1.7M |
| Operating Expenses | $1.8M | $2.4M | $2.3M | $2.1M | $2.6M | $4.1M | $3.6M | $4.5M | $5.7M | $5.8M |
| Operating Income | -$2.2M | -$2.4M | -$2.3M | -$2.1M | -$2.6M | -$4.1M | -$3.6M | -$4.5M | -$5.7M | -$5.8M |
| EBITDA | -$2.3M | -$2.4M | -$2.3M | -$2.1M | -$2.6M | -$4.1M | -$3.4M | -$4.5M | -$5.5M | -$8.0M |
| Interest Expense | $7162 | $13890 | $2790 | $15886 | $246178 | $496912 | $137456 | $107682 | 0 | $296895 |
| Pre-tax Income | -$2.3M | -$2.3M | -$2.6M | -$1.8M | -$2.5M | -$4.5M | -$3.6M | -$5.0M | -$5.5M | -$5.2M |
| Income Tax | 0 | 0 | 0 | $15886 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$2.3M | -$2.3M | -$2.6M | -$1.8M | -$2.5M | -$4.5M | -$3.6M | -$5.0M | -$5.5M | -$5.2M |
| EPS | $-1.72 | $-0.88 | $-1.00 | $-0.69 | $-1.00 | $-1.24 | $-0.82 | $-1.15 | $-1.13 | $-3.45 |
| EPS (Diluted) | $-1.72 | $-0.88 | $-1.00 | $-0.69 | $-1.00 | $-1.24 | $-0.82 | $-1.15 | $-1.13 | $-3.45 |
| Shares Outstanding (Diluted) | $1.3M | $2.6M | $2.6M | $2.6M | $2.6M | $3.7M | $4.3M | $4.3M | $4.9M | $1.9M |
Price
| Price | $0.84 |
| Market Cap | $2M |
| Exchange | OTC |
| Country | US |
Related companies: ARTL · CARM · GTBP · INDP · LIPO · PBM · REVB
Explore sector: Healthcare · Biotechnology
More sections of PTIX: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks